Previous product
Back to products
Calquence (acalabrutinib)
CHF19,946.55
Next product
Lorviqua (lorlatinib)
CHF4,656.03
Libtayo (cemiplimab)
CHF8,328.00
Libtayo (cemiplimab) is a medication used for the treatment of advanced cutaneous squamous cell carcinoma (CSCC), advanced basal cell carcinoma (BCC) and advanced non-small cell lung cancer (NSCLC).
Reviews
There are no reviews yet.